CHECK OUT OUR MAY ISSUE
 
Urology Times cover
View the latest issue online.
Data reveal prevalence of advanced prostate cancer states
Findings from a systematic literature review further our understanding of the prevalence of distinct clinical states of advanced prostate cancer, their association with homologous recombination repair gene alterations, and the use of testing methods to identify HRR gene alterations, researchers say.
Dr. Shore discusses data
 
MOSES-enabled pulsed laser allows same-day discharge without catheter
The benefits of holmium laser enucleation of the prostate with MOSES-enabled pulsed laser modulation justify its consideration as the gold standard surgical treatment for lower urinary tract symptoms related to BPH, according to Amy E. Krambeck, MD.
Learn more
 
SURVEY
 
Is DRE still a relevant tool in the management of prostate cancer?
 
MORE FROM UROLOGY TIMES:
 
Multifaceted approach addresses pandemic’s threat to prostate cancer care
Is MRI fusion Bx the new gold standard for diagnosing PCa?